Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2010
05/12/2010CN101703484A Preparation method of hexadecadrol sodium phosphate freeze-dried powder injection
05/12/2010CN101703479A Resveratrol pellet and preparation method thereof
05/12/2010CN101703477A Coenzyme Q10 mini-pill and preparation method thereof
05/12/2010CN101703467A Acid containing oxaliplatin formulations
05/12/2010CN101703462A Rubescensine B high dispersion preparation
05/12/2010CN101503394B High piperazine acetydrazide derivatives, and preparation and use thereof
05/12/2010CN101422585B Pharmaceutical use of medicine composition containing zedoary turmeric oil
05/12/2010CN101220100B Separation and purification method for squash polyoses and use of obtained component
05/12/2010CN101200752B Method for separation and preparation of eburicoic acid compound by using hirschioporus versatilis fermentation liquor
05/12/2010CN101190210B Application of triacontanol in preparing anti-cancer medicine
05/12/2010CN101164621B Super-paramagnetic composite particle drug-loaded body and preparation method thereof
05/12/2010CN101153041B 1,2,3-triazole 1,3-nitrogen heterocyclic compound, producing method and application of the same
05/12/2010CN101143155B Double ginseng composition and its application
05/12/2010CN101113146B Process for the separation of blood fat recovery purpose-made monascus active ingredient
05/12/2010CN101092419B (1Z, 4Z, 5Z) - 6 N alkyl - 6 - aza -2 - oxo - 3 - oxa - 4 - methoxy - dicyclo [3, 1, 0] hexane and preparation method and use thereof
05/12/2010CN101058604B FK gene, coding protein and application thereof
05/12/2010CN101049506B DNA preparation of virus M protein of bubble stomatitis, preparation method and application
05/12/2010CN101045066B Temperature sensing matter used for preparing medicine to inhibiting tumor angiogenesis, and its use
05/12/2010CN101027290B Novel 2,3-phthalazinone derivatives, as AURORA-A kinase inhibitors
05/12/2010CN101019641B Process of producing black food containing plant melanin
05/11/2010US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
05/11/2010US7714151 4',7-Dihydroxyisoflavanone (phenyl)hydrazone; 4,7-Dihydroxyisoflavanone(4,7-dihydroxyisoflavanone)hydrazone; anticarcinogenic and antiinflammatory agents; cyclooxygenase inhibitor
05/11/2010US7714138 Monocyclic heterocycles as kinase inhibitors
05/11/2010US7714108 Mammalian tumor susceptibility gene products and their uses
05/11/2010US7714026 Pharmaceutical composition containing bakuchiol for treating woman osteoporosis
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7713999 Thrombin receptor antagonists
05/11/2010US7713992 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders
05/11/2010US7713987 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role
05/11/2010US7713983 Voltage gated sodium and calcium channel inhibitors
05/11/2010US7713969 Compositions and methods for treatment of cancer
05/11/2010US7713948 Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs
05/11/2010US7713943 as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target
05/11/2010US7713939 1-Substituted-[1H-indene-6,1'-cyclopropane]-4-one derivatives: solid tumors and multi-drug resistant tumors; -cell leukemia, B-cell lymphoma, myeloma, T-cell leukemia, T-cell lymphoma, small leukemia, and small cell lymphoma
05/11/2010US7713915 cloning; ribosome inactivating protein
05/11/2010US7713710 Isolation and use of solid tumor stem cells
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713524 treating hemolytic disease of the newborn, Sezary Syndrome, chronic myeloid leukemias, chronic lymphoid leukemias (CLL-B), cancer, breast cancer, conditions related to the environment, infectious diseases, chronic fatigue syndrome (CFS), parasitic infections, or viral infections
05/11/2010US7713514 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
05/11/2010CA2503663C Novel quinoxalinone derivatives
05/11/2010CA2468953C Taxane derivative crystal and method for preparing the same
05/11/2010CA2438260C Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
05/11/2010CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2413134C Quinazoline ditosylate salt compounds
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2403871C Inhibition of angiogenesis and tumor growth
05/11/2010CA2400612C Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/11/2010CA2294709C Compositions and methods for enhancing delivery of therapeutic agents to cells
05/11/2010CA2184493C Methods and compositions useful for inhibition of angiogenesis
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/10/2010CA2780482A1 Hdl particles for delivery of nucleic acids
05/06/2010WO2010051533A2 Compositions of engineered human arginases and methods for treating cancer
05/06/2010WO2010051502A2 Light targeting molecules and uses thereof
05/06/2010WO2010051391A1 Use of anti-cs1 antibodies for treatment of rare lymphomas
05/06/2010WO2010051127A2 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors
05/06/2010WO2010051105A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
05/06/2010WO2010051048A1 Microrna modulators and method for identifying and using the same
05/06/2010WO2010050913A1 Vaccination with poxvirus vectors via mechanical epidermal disruption
05/06/2010WO2010050583A1 Agent having anti-helicobacter pylori activity
05/06/2010WO2010050528A1 Anti-muc1 antibody
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010050422A1 Agent for treatment of diabetes
05/06/2010WO2010050328A1 Tumor metastasis inhibitor
05/06/2010WO2010050268A1 Molecular marker for cancer stem cell
05/06/2010WO2010050190A1 Molecular marker for cancer stem cell
05/06/2010WO2010050181A1 Vaccine for preventing onset and recurrence of liver cancer induced by hepatitis c virus
05/06/2010WO2010050178A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound
05/06/2010WO2010049915A1 Poly-heteroaryl derivatives for the treatment of cancer
05/06/2010WO2010049816A2 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof
05/06/2010WO2010049731A1 Pyrazolo- and imidazopyridinylpyrimidineamines as igf-1r tyrosine kinase inhibitors
05/06/2010WO2010049481A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
05/06/2010WO2010049451A2 C-glycosidic analogues of alpha-galactosylceramids having immunostimulating and immunoregulating properties
05/06/2010WO2010049449A2 Novel salts of sunitinib
05/06/2010WO2010049438A2 Improved methods of using phosphoantigens for the treatment of diseases
05/06/2010WO2010048880A1 The nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
05/06/2010WO2010048712A1 Ciclopirox and cytarabine for the treatment of leukemic disorders
05/06/2010WO2010030167A3 Method of detection and diagnosis of oral and nasopharyngeal cancers
05/06/2010WO2010029577A3 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
05/06/2010WO2010027848A3 Forms of lapatinib compounds and processes for the preparation thereof
05/06/2010WO2010019103A9 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer
05/06/2010WO2010014975A3 Use of microrna signatures for assessing risk levels of neuroblastoma patients
05/06/2010WO2010014751A3 Monoclonal antibody zt/2f2 in targeted therapy of cancers overexpressing the ron receptor tyrosine kinase
05/06/2010WO2010008554A3 Methods and products for treating proliferative diseases
05/06/2010WO2010006136A3 Adenovirus targeting
05/06/2010WO2010002970A3 Isolation of cyclopamine
05/06/2010WO2009155527A9 Phosphatidylinositol 3 kinase inhibitors
05/06/2010WO2009153597A3 Compositions with and process for methylmorpholin-subsituted pyrido [2, 3-d] pyrimidines
05/06/2010WO2009151910A3 Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
05/06/2010WO2009151598A8 Diazacarbazoles and methods of use
05/06/2010WO2009144719A3 Methods of killing cells and use of same in prevention and treatment of cancer
05/06/2010WO2009138600A3 Novel uses of d-mannopyranose derivatives activating angiogenesis
05/06/2010WO2009121631A3 Nanoparticles for targeted delivery of active agents to the lung
05/06/2010WO2009106749A3 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
05/06/2010WO2009104198A3 Metal conjugates of indole 3-aldehyde azine and its derivatives and uses thereof
05/06/2010WO2009013543A3 Targeted binging agents directed to kdr and uses thereof - 035
05/06/2010US20100115639 Antibodies inhibiting c-met dimerization and uses thereof
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 2211